Woman 👩, 67 yo, No medical history, Cr ↗️ 1.4 -> 2.8 -> 3.5, oliguria, ESR 124. HTLV1 (+) ANCA (-) C3 and C4 normal, Prot 20g/24h U-sed: glomerular hematuria (10% acanthocytes) + bacteriuria.
December 19, 2025 at 9:19 PM
Woman 👩, 67 yo, No medical history, Cr ↗️ 1.4 -> 2.8 -> 3.5, oliguria, ESR 124. HTLV1 (+) ANCA (-) C3 and C4 normal, Prot 20g/24h U-sed: glomerular hematuria (10% acanthocytes) + bacteriuria.
Single-cell insights reveal how “periodic” TCR signalling shapes self-reactive T cells, and how HTLV-1 exploits this pathway. A fresh model with implications for cancer and immunotherapy. 🧬
Read here: vist.ly/543sa
#Immunology #Tcells #HTLV1
Read here: vist.ly/543sa
#Immunology #Tcells #HTLV1
Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1
Summary. Despite extensive regulatory T cell (Treg) research, fundamental questions on in vivo dynamics remain to be answered. The current study aims to di
doi.org
May 13, 2026 at 4:35 PM
Single-cell insights reveal how “periodic” TCR signalling shapes self-reactive T cells, and how HTLV-1 exploits this pathway. A fresh model with implications for cancer and immunotherapy. 🧬
Read here: vist.ly/543sa
#Immunology #Tcells #HTLV1
Read here: vist.ly/543sa
#Immunology #Tcells #HTLV1
Ich kenne jemand, der unter Verdacht steht, eine sehr seltene Leukämieart zu entwickeln: Adulte T-Zell-Leukämie (Die Person leidet an HTLV1).
Welche Untersuchungen (Blut und Bild, evtl Biopsie) genau sollte der Hausarzt machen lassen?
Bisher stochert er in Dunkeln und eine Videosprechstunde
Welche Untersuchungen (Blut und Bild, evtl Biopsie) genau sollte der Hausarzt machen lassen?
Bisher stochert er in Dunkeln und eine Videosprechstunde
October 17, 2023 at 6:51 PM
Ich kenne jemand, der unter Verdacht steht, eine sehr seltene Leukämieart zu entwickeln: Adulte T-Zell-Leukämie (Die Person leidet an HTLV1).
Welche Untersuchungen (Blut und Bild, evtl Biopsie) genau sollte der Hausarzt machen lassen?
Bisher stochert er in Dunkeln und eine Videosprechstunde
Welche Untersuchungen (Blut und Bild, evtl Biopsie) genau sollte der Hausarzt machen lassen?
Bisher stochert er in Dunkeln und eine Videosprechstunde
#GVNCenterHighlight The Centre for Research in Infectious Diseases at University College Dublin is a GVN COE advancing research on #HTLV1, blood-borne viruses, & viral zoonoses. Its work strengthens infectious disease research & global scientific collaboration.
Learn: https://ow.ly/g98O50Z8UkI
Learn: https://ow.ly/g98O50Z8UkI
June 24, 2026 at 9:00 AM
#GVNCenterHighlight The Centre for Research in Infectious Diseases at University College Dublin is a GVN COE advancing research on #HTLV1, blood-borne viruses, & viral zoonoses. Its work strengthens infectious disease research & global scientific collaboration.
Learn: https://ow.ly/g98O50Z8UkI
Learn: https://ow.ly/g98O50Z8UkI
Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy #HTLV1 #MECFS #LongCovid
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy
An official website of the United States government
pmc.ncbi.nlm.nih.gov
February 26, 2026 at 2:56 PM
Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy #HTLV1 #MECFS #LongCovid
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
🔢 Today's Press Release Highlights from Medianet 🔢
www.linkedin.com/pulse/newsma...
#Homelessness #HousingCrisis #GazaVigil #HTLV1 #WomensGiving #SheGives #Philanthropy #AustraliaNews #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
www.linkedin.com/pulse/newsma...
#Homelessness #HousingCrisis #GazaVigil #HTLV1 #WomensGiving #SheGives #Philanthropy #AustraliaNews #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
NewsMatch Alert: Press Release Summary | 22 July 2025
Welcome to Medianet’s daily media alert featuring a curated list of today's most newsworthy press releases handpicked by our editorial team. Today's highlights Women and girls at centre of worsening h...
www.linkedin.com
July 22, 2025 at 5:55 AM
🔢 Today's Press Release Highlights from Medianet 🔢
www.linkedin.com/pulse/newsma...
#Homelessness #HousingCrisis #GazaVigil #HTLV1 #WomensGiving #SheGives #Philanthropy #AustraliaNews #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
www.linkedin.com/pulse/newsma...
#Homelessness #HousingCrisis #GazaVigil #HTLV1 #WomensGiving #SheGives #Philanthropy #AustraliaNews #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
🚨 NEW RESEARCH! ⚕️ 🩺
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1 - Communications Medicine
Fernandez et al. compare the HTLV-1 proviral load in people with HIV-1-HTLV-1 coinfection on stable antiretroviral therapy or people with HTLV-1 single infection without antiretroviral therapy. Dolutegravir use for longer than six months is associated with lower HTLV-1 proviral load.
dlvr.it
March 5, 2026 at 12:37 PM
🚨 NEW RESEARCH! ⚕️ 🩺
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
WHO to Develop First Global Guidelines on Human T-Cell Lymphotropic Virus-1 (HTLV-1) Prevention and Testing wiobs.com/who-to-devel... #WHO #HTLV1 #PublicHealth #GlobalHealth #ViralDiseases
WHO to Develop First Global Guidelines on Human T-Cell Lymphotropic Virus-1 (HTLV-1) Prevention and Testing -
WHO will draft its first global guidelines on Human T-cell lymphotropic virus-1 (HTLV-1) testing and prevention, marking a critical s
wiobs.com
October 13, 2025 at 9:07 AM
WHO to Develop First Global Guidelines on Human T-Cell Lymphotropic Virus-1 (HTLV-1) Prevention and Testing wiobs.com/who-to-devel... #WHO #HTLV1 #PublicHealth #GlobalHealth #ViralDiseases
CRMP2 expression and function is already validated in human lymphocytes from patients with HTLV1 and MS. Which brings a lot of translational relevance to this manuscript. It's all very exciting
academic.oup.com/jimmunol/art...
academic.oup.com/jimmunol/art...
academic.oup.com/jimmunol/art...
academic.oup.com/jimmunol/art...
August 18, 2025 at 1:48 PM
CRMP2 expression and function is already validated in human lymphocytes from patients with HTLV1 and MS. Which brings a lot of translational relevance to this manuscript. It's all very exciting
academic.oup.com/jimmunol/art...
academic.oup.com/jimmunol/art...
academic.oup.com/jimmunol/art...
academic.oup.com/jimmunol/art...
HTLV1-associated myelopathy as a translational model of progressive neurodegeneration pubmed.ncbi.nlm.nih.gov/41926707/
April 3, 2026 at 7:01 PM
HTLV1-associated myelopathy as a translational model of progressive neurodegeneration pubmed.ncbi.nlm.nih.gov/41926707/
「医療 感染 総合」に関する記事です: https://www.qlifepro.com/news/20260625/htlv1-eye.html
眼科受診で発覚するHTLV-1、都市部の20代など若年層の水平感染に注意－科学大 | QLifePro
東京科学大学は、東京の眼科診療でみられるレトロウイルス（HTLV-1、HIV）感染患者の臨床像を比較し、感染発見の契機や年齢分布、全身合併の違いを解明したと発表した
www.qlifepro.com
June 25, 2026 at 3:23 PM
「医療 感染 総合」に関する記事です: https://www.qlifepro.com/news/20260625/htlv1-eye.html
www.ncbi.nlm.nih.gov/pmc/articles...
"Further investigation shows that the mitochondria in cell lines with EBV Type 3 latency produce higher levels of mitochondrial ROS that are responsible for the activation of the Keap1-NRF2 pathway, compared with Type 1 latency."
"Further investigation shows that the mitochondria in cell lines with EBV Type 3 latency produce higher levels of mitochondrial ROS that are responsible for the activation of the Keap1-NRF2 pathway, compared with Type 1 latency."
The master antioxidant defense is activated during EBV latent infection
Our recent publication shows for the first time that the master antioxidant pathway Keap1-NRF2 is constitutively activated in EBV- or HTLV1-transformed cells, with the mechanism being unclear (L. Wang...
www.ncbi.nlm.nih.gov
June 4, 2025 at 12:03 AM
www.ncbi.nlm.nih.gov/pmc/articles...
"Further investigation shows that the mitochondria in cell lines with EBV Type 3 latency produce higher levels of mitochondrial ROS that are responsible for the activation of the Keap1-NRF2 pathway, compared with Type 1 latency."
"Further investigation shows that the mitochondria in cell lines with EBV Type 3 latency produce higher levels of mitochondrial ROS that are responsible for the activation of the Keap1-NRF2 pathway, compared with Type 1 latency."
The master antioxidant defense is activated during EBV latent infection
www.ncbi.nlm.nih.gov/pmc/articles...
www.ncbi.nlm.nih.gov/pmc/articles...
The master antioxidant defense is activated during EBV latent infection
Our recent publication shows for the first time that the master antioxidant pathway Keap1-NRF2 is constitutively activated in EBV- or HTLV1-transformed cells, with the mechanism being unclear (L. Wang...
www.ncbi.nlm.nih.gov
June 4, 2025 at 12:03 AM
The master antioxidant defense is activated during EBV latent infection
www.ncbi.nlm.nih.gov/pmc/articles...
www.ncbi.nlm.nih.gov/pmc/articles...
【ブログ更新】
白血病発症リスクとHTLV-1ウイルス：UMKテレビ宮崎が伝える、研究最前線の希望
#HTLV1 #白血病 #医療研究 #健康情報 https://kenko-mosunon.blogspot.com/2025/11/htlv-1umk.html
白血病発症リスクとHTLV-1ウイルス：UMKテレビ宮崎が伝える、研究最前線の希望
#HTLV1 #白血病 #医療研究 #健康情報 https://kenko-mosunon.blogspot.com/2025/11/htlv-1umk.html
November 10, 2025 at 11:05 AM
【ブログ更新】
白血病発症リスクとHTLV-1ウイルス：UMKテレビ宮崎が伝える、研究最前線の希望
#HTLV1 #白血病 #医療研究 #健康情報 https://kenko-mosunon.blogspot.com/2025/11/htlv-1umk.html
白血病発症リスクとHTLV-1ウイルス：UMKテレビ宮崎が伝える、研究最前線の希望
#HTLV1 #白血病 #医療研究 #健康情報 https://kenko-mosunon.blogspot.com/2025/11/htlv-1umk.html